Opening book details…
About this book
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial by Nizar J. Bahlis & Caitlin L. Costello & Noopur S. Raje & Moshe Y. Levy & Bhagirathbhai Dholaria & Melhem Solh & Michael H. Tomasson & Michael A. Damore & Sibo Jiang & Cynthia Basu & Athanasia Skoura & Edward M. Chan & Suzanne Trudel & Andrzej... is a book available to read on EtoBox.
- Author
- Nizar J. Bahlis & Caitlin L. Costello & Noopur S. Raje & Moshe Y. Levy & Bhagirathbhai Dholaria & Melhem Solh & Michael H. Tomasson & Michael A. Damore & Sibo Jiang & Cynthia Basu & Athanasia Skoura & Edward M. Chan & Suzanne Trudel & Andrzej...
- Publisher
- Springer US
- Published
- 2023
- Language
- EN
More by Nizar J. Bahlis & Caitlin L. Costello & Noopur S. Raje & Moshe Y. Levy & Bhagirathbhai Dholaria & Melhem Solh & Michael H. Tomasson & Michael A. Damore & Sibo Jiang & Cynthia Basu & Athanasia Skoura & Edward M. Chan & Suzanne Trudel & Andrzej...
Similar books
- Elranatamab in Relapsed or Refractory Multiple Myeloma: Phase 2 MagnetisMM-3 Trial Results — Alexander M. Lesokhin & Michael H. Tomasson & Bertrand Arnulf & Nizar J. Bahlis & H. Miles Prince & Ruben Niesvizky & Paula Rodrίguez-Otero & Joaquin Martinez-Lopez & Guenther Koehne & Cyrille Touzeau & Yogesh Jethava & Hang Quach & Julien Depaus &... (2023)
- Allogeneic BCMA-targeting CAR T Cells in Relapsed/refractory Multiple Myeloma: Phase 1 UNIVERSAL Trial Interim Results — Sham Mailankody & Jeffrey V. Matous & Saurabh Chhabra & Michaela Liedtke & Surbhi Sidana & Olalekan O. Oluwole & Shahbaz Malik & Rajneesh Nath & Faiz Anwer & Jose Carlos Cruz & Myo Htut & Erin E. Karski & Wade Lovelace & Myles Dillon & Eric Butz &... (2023)
- Idecabtagene Vicleucel for Relapsed and Refractory Multiple Myeloma: Post Hoc 18-Month Follow-up of a Phase 1 Trial — Yi Lin & Noopur S. Raje & Jesús G. Berdeja & David S. Siegel & Sundar Jagannath & Deepu Madduri & Michaela Liedtke & Jacalyn Rosenblatt & Marcela V. Maus & Monica Massaro & Fabio Petrocca & Ashish Yeri & Olivia Finney & Andrea Caia & Zhihong Yang &... (2023)
- Belantamab Mafodotin, Pomalidomide and Dexamethasone in Refractory Multiple Myeloma: a Phase 1/2 Trial — Suzanne Trudel & Arleigh McCurdy & Martha L. Louzada & Stephen Parkin & Darrell White & Michael P. Chu & Rami Kotb & Hira Mian & Ibraheem Othman & Jiandong Su & Aniba Khan & Engin Gul & Donna Reece (2024)
- Lorlatinib with or Without Chemotherapy in ALK-driven Refractory/relapsed Neuroblastoma: Phase 1 Trial Results — Kelly C. Goldsmith & Julie R. Park & Kimberly Kayser & Jemily Malvar & Yueh-Yun Chi & Susan G. Groshen & Judith G. Villablanca & Kateryna Krytska & Lillian M. Lai & Patricia T. Acharya & Fariba Goodarzian & Bruce Pawel & Hiroyuki Shimada & Susan... (2023)
- Anti-GD2 CAR-NKT Cells in Relapsed or Refractory Neuroblastoma: Updated Phase 1 Trial Interim Results — Andras Heczey & Xin Xu & Amy N. Courtney & Gengwen Tian & Gabriel A. Barragan & Linjie Guo & Claudia Martinez Amador & Nisha Ghatwai & Purva Rathi & Michael S. Wood & Yanchuan Li & Chunchao Zhang & Thorsten Demberg & Erica J. Di Pierro & Andrew C. Sher... (2024)